The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®

被引：0
作者：
F. Borgström
O. Ström
J. Coelho
H. Johansson
A. Oden
E. V. McCloskey
J. A. Kanis
机构：
[1] Karolinska Institute,Medical Management Centre
[2] I3 Innovus,undefined
[3] Centre for Metabolic Bone Diseases (WHO Collaborating Centre) University of Sheffield Medical School,undefined
来源：
Osteoporosis International | 2010年 / 21卷
关键词：
Cost-effectiveness; Fractures; FRAX; Osteoporosis; QALY;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 505
页数：10
相关论文
共 50 条
  • [1] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA®
    Borgstrom, F.
    Strom, O.
    Coelho, J.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (03) : 495 - 505
  • [2] The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
    F. Borgström
    O. Ström
    J. Coelho
    H. Johansson
    A. Oden
    E. McCloskey
    J. A. Kanis
    Osteoporosis International, 2010, 21 : 339 - 349
  • [3] The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
    Borgstrom, F.
    Strom, O.
    Coelho, J.
    Johansson, H.
    Oden, A.
    McCloskey, E.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (02) : 339 - 349
  • [4] Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
    O. Ström
    B. Jönsson
    J. A. Kanis
    Osteoporosis International, 2013, 24 : 1491 - 1502
  • [5] The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
    F. Borgström
    Å. Carlsson
    H. Sintonen
    S. Boonen
    P. Haentjens
    R. Burge
    O. Johnell
    B. Jönsson
    J. A. Kanis
    Osteoporosis International, 2006, 17 : 996 - 1007
  • [6] Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
    Chandran, M.
    Ganesan, G.
    Tan, K. B.
    Reginster, J-Y
    Hiligsmann, M.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (01) : 133 - 144
  • [7] Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis
    Nagendra, Lakshmi
    Chandran, Manju
    Reginster, Jean-Yves
    Bhadada, Sanjay Kumar
    Bhattacharya, Saptarshi
    Dutta, Deep
    Hiligsmann, Mickael
    OSTEOPOROSIS INTERNATIONAL, 2025, 36 (02) : 311 - 322
  • [8] Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
    M. Chandran
    G. Ganesan
    K.B. Tan
    J.-Y. Reginster
    M. Hiligsmann
    Osteoporosis International, 2021, 32 : 133 - 144
  • [9] The cost-effectiveness of risedronate in the treatment of osteoporosis:: an international perspective
    Borgstrom, F.
    Carlsson, A.
    Sintonen, H.
    Boonen, S.
    Haentjens, P.
    Burge, R.
    Johnell, O.
    Jonsson, B.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 (07) : 996 - 1007
  • [10] Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
    Andréa Marques
    Óscar Lourenço
    Gustaf Ortsäter
    Fredrik Borgström
    John A. Kanis
    José António P. da Silva
    Calcified Tissue International, 2016, 99 : 131 - 141
12345